Margaret E. McCann

1.5k total citations
19 papers, 550 citations indexed

About

Margaret E. McCann is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, Margaret E. McCann has authored 19 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Physiology. Recurrent topics in Margaret E. McCann's work include Peroxisome Proliferator-Activated Receptors (6 papers), Adipose Tissue and Metabolism (5 papers) and Cholesterol and Lipid Metabolism (4 papers). Margaret E. McCann is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (6 papers), Adipose Tissue and Metabolism (5 papers) and Cholesterol and Lipid Metabolism (4 papers). Margaret E. McCann collaborates with scholars based in United States, Canada and China. Margaret E. McCann's co-authors include Gerard J. Hickey, W. Cameron Black, Christine Brideau, L. Krulich, Joel P. Berger, Harold B. Wood, Peter T. Meinke, Donghui Zhang, P Hanson and Margaret Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Margaret E. McCann

17 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret E. McCann United States 14 236 138 122 76 71 19 550
H H Tai United States 9 127 0.5× 21 0.2× 158 1.3× 36 0.5× 18 0.3× 22 391
Jacqueline Bonnet France 11 178 0.8× 37 0.3× 75 0.6× 40 0.5× 13 0.2× 13 531
Carlo van Staden United States 6 139 0.6× 15 0.1× 153 1.3× 13 0.2× 12 0.2× 9 313
B. A. John United States 11 113 0.5× 27 0.2× 50 0.4× 39 0.5× 31 0.4× 19 446
Hidenobu Kusuhara Japan 8 86 0.4× 229 1.7× 110 0.9× 23 0.3× 14 0.2× 10 418
Atle Bessesen Norway 12 140 0.6× 49 0.4× 75 0.6× 46 0.6× 38 0.5× 22 438
J Birnbaum United States 7 162 0.7× 91 0.7× 48 0.4× 54 0.7× 53 0.7× 14 455
Fusao Ueda Japan 15 297 1.3× 87 0.6× 86 0.7× 18 0.2× 16 0.2× 37 553
Stephen L. Underwood United Kingdom 12 171 0.7× 28 0.2× 41 0.3× 36 0.5× 19 0.3× 16 588
C. S. McFarlane Canada 14 199 0.8× 29 0.2× 135 1.1× 74 1.0× 7 0.1× 20 619

Countries citing papers authored by Margaret E. McCann

Since Specialization
Citations

This map shows the geographic impact of Margaret E. McCann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret E. McCann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret E. McCann more than expected).

Fields of papers citing papers by Margaret E. McCann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret E. McCann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret E. McCann. The network helps show where Margaret E. McCann may publish in the future.

Co-authorship network of co-authors of Margaret E. McCann

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret E. McCann. A scholar is included among the top collaborators of Margaret E. McCann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret E. McCann. Margaret E. McCann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Liu, Weiguo, Kun Liu, Harold B. Wood, et al.. (2011). Benzimidazolones: A New Class of Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators. Journal of Medicinal Chemistry. 54(24). 8541–8554. 48 indexed citations
3.
DeVita, Robert J., Margarita García‐Calvo, Roger Meurer, et al.. (2010). Spiroimidazolidinone NPC1L1 inhibitors. Part 2: Structure–activity studies and in vivo efficacy. Bioorganic & Medicinal Chemistry Letters. 20(23). 6929–6932. 15 indexed citations
4.
McMasters, Daniel R., Margarita García‐Calvo, Vladimir N. Maiorov, et al.. (2009). Spiroimidazolidinone NPC1L1 inhibitors. 1: Discovery by 3D-similarity-based virtual screening. Bioorganic & Medicinal Chemistry Letters. 19(11). 2965–2968. 14 indexed citations
5.
Liu, Weiguo, Kun Liu, Harold B. Wood, et al.. (2009). Discovery of a Peroxisome Proliferator Activated Receptor γ (PPARγ) Modulator with Balanced PPARα Activity for the Treatment of Type 2 Diabetes and Dyslipidemia. Journal of Medicinal Chemistry. 52(14). 4443–4453. 18 indexed citations
6.
7.
Weinglass, Adam B., Martin Köhler, Jessica Liu, et al.. (2008). Madin-Darby Canine Kidney II Cells: A Pharmacologically Validated System for NPC1L1-Mediated Cholesterol Uptake. Molecular Pharmacology. 73(4). 1072–1084. 22 indexed citations
8.
Chang, Ching H., Lesley A. McNamara, Margaret Wu, et al.. (2008). A novel selective peroxisome proliferator-activator receptor-γ modulator—SPPARγM5 improves insulin sensitivity with diminished adverse cardiovascular effects. European Journal of Pharmacology. 584(1). 192–201. 25 indexed citations
9.
Weinglass, Adam B., Martin Köhler, Uwe Schulte, et al.. (2008). Extracellular loop C of NPC1L1 is important for binding to ezetimibe. Proceedings of the National Academy of Sciences. 105(32). 11140–11145. 95 indexed citations
10.
Carballo‐Jane, Ester, Silvi Luell, Michael W. Wolff, et al.. (2007). Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists. Journal of Pharmacological and Toxicological Methods. 56(3). 308–316. 13 indexed citations
11.
McCann, Margaret E., Eric L. Rickes, Paul Cunningham, et al.. (2005). In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia. American Journal of Veterinary Research. 66(7). 1278–1284. 28 indexed citations
12.
Liu, Kun, Regina M. Black, John J. Acton, et al.. (2005). Selective PPARγ modulators with improved pharmacological profiles. Bioorganic & Medicinal Chemistry Letters. 15(10). 2437–2440. 56 indexed citations
13.
McCann, Margaret E., Donghui Zhang, Christine Brideau, et al.. (2004). In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis. American Journal of Veterinary Research. 65(4). 503–512. 79 indexed citations
14.
McCann, Margaret E., James N. Moore, Joan Carrick, & Michelle Henry Barton. (2000). EFFECT OF INTRAVENOUS INFUSION OF OMEGA-3 AND OMEGA-6 LIPID EMULSIONS ON EQUINE MONOCYTE FATTY ACID COMPOSITION AND INFLAMMATORY MEDIATOR PRODUCTION IN VITRO. Shock. 14(2). 222–228. 26 indexed citations
15.
McCann, Margaret E. & Joan Carrick. (1998). Potential uses of omega-3 fatty acids in equine diseases. Compendium on Continuing Education for The Practicing Veterinarian.
16.
McCann, Margaret E., T. D. G. Watson, F. Douglas Boudinot, & James N. Moore. (1995). Pharmacokinetics of heparin and its pharmacodynamic effect on plasma lipoprotein lipase activity and coagulation in healthy horses. American Journal of Veterinary Research. 56(8). 1070–1074. 3 indexed citations
17.
Hunt, Robert J., et al.. (1994). Effects of acetylpromazine, xylazine, and vertical load on digital arterial blood flow in horses. American Journal of Veterinary Research. 55(3). 375–378. 31 indexed citations
18.
Krulich, L. & Margaret E. McCann. (1969). Effect of GH-Releasing Factor and GH-Inhibiting Factor on the Release and Concentration of GH in Pituitaries Incubatedin Vitro. Endocrinology. 85(2). 319–324. 27 indexed citations
19.
McCann, Margaret E.. (1966). Group Reconstruction: A Technique for Studying the Why's of Behavior. AJN American Journal of Nursing. 66(9). 1995–1995.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H H Tai Breakdown of academic impact, for papers by Jacqueline Bonnet Breakdown of academic impact, for papers by Carlo van Staden Breakdown of academic impact, for papers by B. A. John Breakdown of academic impact, for papers by Hidenobu Kusuhara Breakdown of academic impact, for papers by Atle Bessesen Breakdown of academic impact, for papers by J Birnbaum Breakdown of academic impact, for papers by Fusao Ueda Breakdown of academic impact, for papers by Stephen L. Underwood Breakdown of academic impact, for papers by C. S. McFarlane
Rankless by CCL
2026